| 13.08.2026 | Naveruclif 5 mg/ml (100 mg paclitaxel) x1fl.pulb.perf. - REF NR 15314/12.08.2026 - ONCOLOGIE |
1.600 lei | 1.600 lei |
— |
Fildas Trading |
DA40986723 |
Antineoplazice (Rev.2) |
Pitesti |
33652100-6 |
| 10.08.2026 | HERCEPTIN 150mg*1flac. (DCI: TRASTUZUMABUM) - REF NR 14774/05.08.2026 - ONCOLOGIE |
3.986 lei | 3.986 lei |
— |
Roche Romania |
DA40967484 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 28.07.2026 | Naveruclif 5 mg / ml (100 mg paclitaxel) x 1 flac. pulb. pt. dispersie perf. / PACLITAXELUM - R14264 |
1.600 lei | 1.600 lei |
— |
Fildas Trading |
DA40896679 |
Antineoplazice (Rev.2) |
Pitesti |
33652100-6 |
| 24.07.2026 | Herceptin 150mg pulb.conc.sol.perf*1fl F HRF(TRASTUZUMABUM) - REF NR 14147/24.07.2026 - ONCOLOGIE |
3.879 lei | 3.879 lei |
— |
Alliance Healthcare Romania |
DA40884601 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 25.06.2026 | Dacarbazina Lipomed 200mg pulb.sol.inj/perf*10fl ATV(DACARBAZINUM)_REF.NR. 12157/25.06.2026 |
1.095 lei | 1.095 lei |
— |
Alliance Healthcare Romania |
DA40709281 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 09.06.2026 | Herceptin 150mg pulb.conc.sol.perf*1fl F HRF(TRASTUZUMABUM) - REF NR 11143/09.06.2026 - ONCOLOGIE |
3.879 lei | 3.879 lei |
— |
Alliance Healthcare Romania |
DA40588029 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 20.05.2026 | Dacarbazina Lipomed 200mg pulb.sol.inj/perf*10fl ATV(DACARBAZINUM)- REF NR 9735/19.05.2026-ONCOLOGIE |
1.095 lei | 1.095 lei |
— |
Alliance Healthcare Romania |
DA40433420 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 27.04.2026 | OPDIVO 10MG/ML CONC.PT.SOL.PERF 12MLX 1FL - REF NR 8193/27.04.2026 - ONCOLOGIE - C-V |
17 mii lei | 17 mii lei |
— |
Farmexim S.A. |
DA40257974 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 07.04.2026 | Dacarbazina Lipomed 200mg pulb.sol.inj/perf*10fl - REF NR 6959/03.04.2026 - ONCOLOGIE |
1.095 lei | 1.095 lei |
— |
Alliance Healthcare Romania |
DA40155342 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 03.03.2026 | Dacarbazina Lipomed 200mg pulb.sol.inj/perf*10fl ATV(DACARBAZINUM) - REF 4368/02.03.2026-ONCOLOGIE |
1.096 lei | 1.096 lei |
— |
Alliance Healthcare Romania |
DA39926695 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 16.12.2025 | IRINOTECAN KABI 20 mg/ml_100mg/5ml R.22307/11.12.2025 ONCOLOGIE |
4.559 lei | 4.559 lei |
— |
Fresenius Kabi Romania |
DA39549786 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 15.12.2025 | ACID ZOLENDRONIC FRESENIUS KABI 4mg/5ml- R.22307/11.12.2025 ONCOLOGIE |
4.220 lei | 4.220 lei |
— |
Fresenius Kabi Romania |
DA39531785 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 13.11.2025 | IRINOTECAN KABI 20 mg/ml_100mg/5ml R.19738/07.11.2025 ONCOLOGIE |
2.166 lei | 2.166 lei |
— |
Fresenius Kabi Romania |
DA39281504 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 29.10.2025 | ACID ZOLENDRONIC FRESENIUS KABI 4mg/5ml R.18302/22.10.2025 ONCOLOGIE |
3.376 lei | 3.376 lei |
— |
Fresenius Kabi Romania |
DA39170232 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 17.09.2025 | ACID ZOLENDRONIC FRESENIUS KABI 4mg/5ml - REF. 15781/16.09.2025 - ONCO |
2.405 lei | 2.532 lei |
— |
Fresenius Kabi Romania |
DA38887525 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 06.05.2025 | ACID ZOLEDRONIC FRESENIUS KABI 4mg/5ml - REF NR 7733/05.05.2025 - ONCOLOGIE |
3.207 lei | 3.376 lei |
— |
Fresenius Kabi Romania |
DA38034556 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 28.03.2025 | ACID ZOLEDRONIC FRESENIUS KABI 4mg/5ml - REF NR 5676/27.03.2025 - ONCOLOGIE |
1.202 lei | 1.202 lei |
— |
Fresenius Kabi Romania |
DA37773551 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 12.03.2025 | ACID ZOLENDRONIC FRESENIUS KABI 4mg/5ml - REF NR3431/25.02.2025 - ONCOLOGIE |
1.266 lei | 1.266 lei |
— |
Fresenius Kabi Romania |
DA37651913 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 29.11.2024 | OXALIPLATIN KABI 5mg/ml - 50mg - REF NR 19996/22.11.2024 - ONCOLOGIE |
1.930 lei | 1.930 lei |
— |
Fresenius Kabi Romania |
DA37055092 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 27.11.2024 | Gemcitabina Accord 100mg/ml conc.sol.perf*1fl*10ml - REF NR 19996/22.11.2024 - ONCOLOGIE |
863 lei | 863 lei |
— |
Alliance Healthcare Romania |
DA37034801 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 27.11.2024 | Acid zoledronic Teva conc.sol.perf 4mg/5ml*1fl*5ml - REF NR 19996/22.11.2024 - ONCOLOGIE |
4.124 lei | 4.124 lei |
— |
Alliance Healthcare Romania |
DA37034659 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 15.11.2024 | Acid zoledronic Teva conc.sol.perf 4mg/5ml*1fl*5ml - REF NR 19323/12.11.2024 - ONCOLOGIE |
2.062 lei | 2.062 lei |
— |
Alliance Healthcare Romania |
DA36940502 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 08.10.2024 | OXALIPLATIN KABI 5mg/ml - concentrat 50mg - REF. 16694/04.10.2024 - ONCOL. |
7.721 lei | 7.721 lei |
— |
Fresenius Kabi Romania |
DA36670732 |
Antineoplazice (Rev.2) |
Ghimbav |
33652100-6 |
| 26.08.2024 | Halaven 0.44mg/ml sol.inj*1fl*2ml EWO(ERIBULINUM) - REF NR 14084/21.08.2024 - ONCOLOGIE |
5.923 lei | 5.923 lei |
— |
Alliance Healthcare Romania |
DA36348169 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 22.08.2024 | ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml - REF NR 14084/21.08.2024 - ONCOLOGIE |
12 mii lei | 12 mii lei |
— |
Sermedic |
DA36339732 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 25.06.2024 | ACID ZOLEDRONIC TEVA 4 MG/5 ML X1FL (ACIDUM ZOLEDRONICUM) - R 10221/17.06.2024 - ONCO |
1.573 lei | 1.573 lei |
— |
Farmexim S.A. |
DA36005914 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 07.02.2024 | HALAVEN 0.44MG/ML SOL INJ X 1 FLACON (ERIBULINUM) - REF NR 2228/07.02.2024 - ONCOLOGIE - COST-VOLUM |
5.962 lei | 5.962 lei |
— |
Farmexim S.A. |
DA34989205 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 30.01.2024 | ACCOFIL 30MU/0.5ML X 1SER ((FILGRASTIMUM (G-CSF)) - ref. nr. 1603/29.01.2024 - ONCO |
926 lei | 926 lei |
— |
Farmexim S.A. |
DA34928930 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 30.01.2024 | PEMETREXED DITROMETAMINA 500MG X1FLACON DR. REDDY'S - REF NR 1603/29.01.2024 - ONCOLOGIE |
753 lei | 753 lei |
— |
Farmexim S.A. |
DA34926403 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 29.01.2024 | Vectibix 20mg/ml conc.sol.perf*1fl*5ml F(PANITUMUMABUM) - REF NR 1603/29.01.2024 - ONCO |
3.759 lei | 3.759 lei |
— |
Alliance Healthcare Romania |
DA34924089 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 29.01.2024 | Docetaxel Actavis 20mg/ml conc.sol.perf*1fl*4ml(DOCETAXELUM) - REF NR 1603/29.01.2024 - ONCO |
1.692 lei | 1.692 lei |
— |
Alliance Healthcare Romania |
DA34923894 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 26.01.2024 | HALAVEN 0.44MG/ML SOL INJ X 1 FLACON (ERIBULINUM) - REF NR 1511/26.01.2024 - ONCOLOGIE C-V |
2.981 lei | 2.981 lei |
— |
Farmexim S.A. |
DA34913072 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 26.01.2024 | HALAVEN 0.44MG/ML SOL INJ X 1 FLACON (ERIBULINUM) - REF. 1442/26.01.2024 - ONCO - COST - VOLUM |
2.981 lei | 2.981 lei |
— |
Farmexim S.A. |
DA34908685 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 22.01.2024 | 5-FLUOROURACIL 50MG/ML 1FL X 20ML EBEWE (FLUOROURACILUM) - REF NR 1200/22.01.2024 - ONCOLOGIE |
955 lei | 955 lei |
— |
Farmexim S.A. |
DA34886233 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 16.01.2024 | Halaven 0.44mg/ml sol.inj*1fl*2ml EWO(ERIBULINUM)_1241848_#RX - R 882/16.01.2024 - ONCOL |
2.981 lei | 2.981 lei |
— |
Alliance Healthcare Romania |
DA34851130 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 12.01.2024 | Erbitux 5 mg/ml x 20 ml (Cetuximabum) - REF. NR. 468/10.01.2024 - ONCOL. SPITAL |
2.812 lei | 2.812 lei |
— |
Merck Romania S.R.L. |
DA34827472 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 13.12.2023 | Armisarte 25mg/ml conc.sol.perf*1fl*20ml F(PEMETREXEDUM)-REF NR 21680/12.12.2023-ONCOLOGIE |
4.803 lei | 4.803 lei |
— |
Alliance Healthcare Romania |
DA34694682 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 23.11.2023 | Pemetrexed Dr.Reddy's 500mg pulb.conc.sol.perf*1fl(PEMETREXEDUM) - REF NR 20425/22.11.2023-ONCOLOGIE |
559 lei | 559 lei |
— |
Alliance Healthcare Romania |
DA34558641 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 07.11.2023 | VINORELBINA ACCORD 10 MG/ML CONC PT SOL PERF FL*5 ML-REF NR 19413/07.11.2023 - ONCOLOGIE |
437 lei | 437 lei |
— |
Mediplus Exim |
DA34446413 |
Antineoplazice (Rev.2) |
Mogosoaia |
33652100-6 |
| 04.10.2023 | Vinorelbin 10mg/ml-conc.pt.sol.perf. x 5ml x 1fl-Accord Healthcare-REF NR 17155/03.10.2023-ONCOLOGIE |
376 lei | 376 lei |
— |
Dona. Logistica |
DA34162811 |
Antineoplazice (Rev.2) |
Chitila |
33652100-6 |
| 09.08.2023 | CISPLATINA ACCORD 1MG/ML CT*1FL*50 ML - REF NR 13700/04.08.02023 - ONCOLOGIE |
1.184 lei | 1.184 lei |
— |
Mediplus Exim |
DA33803423 |
Antineoplazice (Rev.2) |
Mogosoaia |
33652100-6 |
| 19.06.2023 | Yondelis 1mg pulb.conc.sol.perf*1fl F(TRABECTEDINUM) - REF NR 10674/16.06.2023 - ONCOLOGIE |
10 mii lei | 10 mii lei |
— |
Alliance Healthcare Romania |
DA33480956 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 13.06.2023 | VINORELBINA ACCORD 10 MG/ML CONC PT SOL PERF FL*5 ML-VINORELBINUM-REF.10393/13.06.2023-ONCOLOGIE |
697 lei | 697 lei |
— |
Mediplus Exim |
DA33446562 |
Antineoplazice (Rev.2) |
Mogosoaia |
33652100-6 |
| 26.04.2023 | Yondelis 1mg pulb.conc.sol.perf*1fl F(TRABECTEDINUM) - REF NR 7563/26.04.2023 - ONCOLOGIE |
10 mii lei | 10 mii lei |
— |
Alliance Healthcare Romania |
DA33103188 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 05.04.2023 | Yondelis 1mg pulb.conc.sol.perf*1fl F(TRABECTEDINUM) - REF NR 6436/05.04.2023 - ONCOLOGIE |
10 mii lei | 10 mii lei |
— |
Alliance Healthcare Romania |
DA32973995 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 17.01.2023 | Bavencio 200 mg ( 20 mg/ml) (Avelumab) - REF NR 939/17.01.2023 - COST-VOLUM - ONCOLOGIE |
32 mii lei | 32 mii lei |
— |
Merck Romania S.R.L. |
DA32394304 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 17.01.2023 | IMFINZI 50MG/ML CONC. PT. SOL. PERF. FL*10ML(DURVALUMABUM) - REF 938/17.01.2023 - ONCOL - COST VOLUM |
29 mii lei | 29 mii lei |
— |
Mediplus Exim |
DA32394145 |
Antineoplazice (Rev.2) |
Mogosoaia |
33652100-6 |
| 16.12.2022 | Bavencio 200 mg ( 20 mg/ml) (Avelumab) - REF NR 24381/16.12.2022 - COST-VOLUM - ONCOLOGIE |
64 mii lei | 64 mii lei |
— |
Merck Romania S.R.L. |
DA32218331 |
Antineoplazice (Rev.2) |
|
33652100-6 |
| 17.11.2022 | Doxorubicina 2mg/ml 25ml x 50mg x 1fl-Accord Healthcare-PL - REF NR 21995/09.11.2022 - ONCOLOGIE |
1.773 lei | 1.773 lei |
— |
Dona. Logistica |
DA31914111 |
Antineoplazice (Rev.2) |
Bucuresti |
33652100-6 |
| 20.09.2022 | CISPLATINA ACCORD 50MG/50ML 1FL X 50ML - REF NR 17748/14.09.2022 - ONCOLOGIOE |
1.350 lei | 1.350 lei |
— |
Farmexim S.A. |
DA31422353 |
Antineoplazice (Rev.2) |
|
33652100-6 |